The US Food and Drug Administration has approved the first ever prescribed medicine for Obstructive Sleep Apnea. Read on to ...

Older adults ... sleep apnea specific antidepressants to treat insomnia dopamine agents for restless leg syndrome and periodic limb movement disorder iron replacement therapy for restless leg ...

Zepbound, a drug approved by the FDA, has been shown to reduce the severity of obstructive sleep apnea in obese adults, ...

5, 2024 — Sleep is ... depression symptoms, directly and indirectly, by improving mood and alleviating insomnia throughout ... Sleep Apnea Contributes to Dementia in Older Adults, Especially ...

Data from recent research involving 400,000 participants revealed that eating cheese influenced 23 biomarkers linked to sleep apnea.

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

Estimated 54 million people suffer from obstructive sleep apnea in the U.S. including 30-50% of adults with hypertension, both conditions ...

Zepbound was found to work on moderate to severe obstructive apnea in adults with obesity ... it seem that the improvement in AHI and sleep apnea symptoms in those with OSA is related to weight ...

“It’s important to understand OSA symptoms and know that treatments ... to continue experiencing a benefit for sleep apnea.” At least 25 million adults in the U.S. have sleep apnea ...

Sleep apnea impacts about 30 million American adults, making it a common sleep disorder. But while plenty of people struggle with symptoms like loud snoring, daytime sleepiness, and morning ...

“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical ...